Supply contract for QC analytical equipment worth ₩5.1bn
Daihan Scientific filed a supply contract for QC analytical equipment with PT Daewoong Pharmaceutical Indonesia, worth ₩5.1bn and reported as 6.3% of revenue. The contract period runs from Oct 7, 2026 to Jan 31, 2027.
Key facts
| Contract name | QC analytical equipment supply contract |
|---|---|
| Counterparty | Daewoong Pharmaceutical Indonesia (PT Daewoong Pharmaceutical Indonesia) |
| Contract amount | ₩5.1bn |
| % of revenue (as reported) | 6.3% |
| Period start | Oct 7, 2026 |
| Period end | Jan 31, 2027 |
Comparison
| Amount as % of FY2025 revenue (calculated) | 6.3% |
|---|---|
| Revenue 2025 | ₩81.1bn |
| Revenue 2024 | ₩71.7bn |
| Revenue 2023 | ₩73.7bn |
Context
In the 12 months before this filing, insiders had net open-market buying of 69,822 shares.
Key metrics
Supply contracts
| Supply contracts, last 12 months | ₩5.1bn |
|---|---|
| Supply contracts vs prior-year revenue | 6.3% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Source: DART (Financial Supervisory Service) · Original filing on DART ↗